Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.01.18.427098

Changing Patterns and Drivers of Increased Pesticides Use in Smallholder Vegetable Production Systems in Tanzania

Abstract

Pesticides use has become a key component of smallholder horticulture production. Therefore, dynamics in pesticides handling need to be ascertained. This study assessed drivers of pesticides use and determinants of changing patterns of pesticides handling practices in smallholder vegetable systems. Data were collected from 385 farmers from Iringa, Arusha, Manyara, and Kilimanjaro regions in Tanzania through an in-depth survey and field observations. A binary probit model was used to derive factors fostering increased pesticides use. Results showed that 47.9 % of all pesticides were wrongly used. Most farmers (88.6%) lacked knowledge of pest control and 88.9% were unaware of safety practices. Disposal methods of empty pesticides foster occupational and environmental exposure (58%). There was an increasing trend in pesticides use (58.4%), accompanied by changing pesticides formulations. Over 60 pesticides with 29 different formulations were used. Mixing pesticides (71.2%), high dose rates with increased frequency of application were observed. Pesticides under Class II WHO hazard (68.9%) dominated. Extremely hazardous (Class Ia) and highly hazardous (Class Ib) were also used. Binary probit model showed that number of crops grown, pesticides mixing, and region contributed positively to the likelihood of increased pesticides use while farmers perception of effectiveness of pesticides, lack of access to safe use information, poor use of safety gears and inability to read pesticides labels had a negative impact. The fate of pesticides use in smallholder vegetable production systems is therefore the culmination of serious health and environmental implications. Excessive pesticides use escalated by increased number of crops, improper use of PPE, and pesticides mixing practices subjects the general population to pesticides environmental exposure thereby jeopardizing sustainability of smallholder vegetable production in Tanzania. Regular training to farmers and extension officers on current and emerging issues on pests and pesticide safe use is vital.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kapeleka, J. A., Sauli, E., Sadik, O., Ndakidemi, P. A.. 2021-01-18. Changing Patterns and Drivers of Increased Pesticides Use in Smallholder Vegetable Production Systems in Tanzania. https://doi.org/10.1101/2021.01.18.427098

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

Antisense oligonucleotides (ASOs) are a powerful therapeutic modality, but their full potential is hindered by pharmacokinetic properties that affect tissue and cellular delivery. Lipid conjugation is increasingly used to modulate ASO's biodistribution and promote extrahepatic activity, yet lipid dependent effects on in vivo functional delivery, particularly in the central nervous system (CNS), remain less explored. Here, we performed a side by side in vivo comparison of cholesterol, palmitic acid (C16:0), docosanoic acid (C22:0), and eicosapentaenoic acid (C20:5) conjugated to a fully phosphorothioated 3 10 3 LNA gapmer ASO targeting the Malat1 long non coding RNA. Lipid-ASO conjugates were administered systemically or locally in the brain of mice and evaluated for tissue level and cellular level distribution by imaging, qPCR and single-cell RNA sequencing, simultaneously annotating cell origin and global transcriptional changes within the cell. Following systemic administration in mice, lipid conjugation improved overall multi organ efficacy compared to unconjugated ASO, but with pronounced tissue specific differences. Single cell sequencing of liver and heart transcriptomes revealed lipid dependent cellular uptake patterns and transcriptional responses distinct from administration of unconjugated ASO. After intracerebroventricular administration, selected fatty acid conjugates enhanced silencing in deep brain regions such as the striatum, whereas cholesterol conjugation impaired functional delivery despite increased CNS retention. Light-sheet microscopy showed restricted parenchymal penetration of cholesterol ASOs compared with broader but heterogeneous distribution of palmitic acid conjugate. Together, these findings demonstrate that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context specific lipid design in ASO therapeutic development.

pharmacology and toxicology↗

Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment

Small interfering RNA (siRNA) enables precise post-transcriptional gene silencing for refractory diseases, yet its clinical translation remains limited by the lack of safe and efficient delivery vectors. Inspired by the dissymmetric alkyl chain architecture of natural membrane phospholipids, we designed and synthesized 34 novel ionizable lipids with dissymmetric hydrophobic tails and formulated them into lipid nanoparticles (LNPs). Through systematic physicochemical and biological assessments, we established clear structure-activity relationships and identified two lead LNPs (O14-LNP, H18a-LNP) with superior endosomal escape capacity, enhanced in vivo gene silencing potency, and favorable biosafety relative to the clinical benchmark MC3-LNP. In both streptozotocin-induced and spontaneous db/db type 2 diabetes (T2D) mouse models, lead LNPs delivering ferroptosis-related siRNAs effectively ameliorated glucose and lipid metabolic disorders, restored islet function, and alleviated hepatic steatosis. This study not only lays a theoretical foundation for the rational design of novel ionizable lipids, but also validates the therapeutic potential of siRNA therapy targeting ferroptosis, providing a versatile delivery platform and targeted therapeutic strategy for the treatment of T2D.

pharmacology and toxicology↗

Differential Activity of Repurposed Drugs as Receptor Binding Domain Antagonists for Omicron and Native Strains of SarsCov2

Omicron strain is the latest variant of concern of SarsCov2 virus. The mutations in this strain in the S protein Receptor Binding domain (RBD) enable it to be more transmissible as well as escape neutralizing activity by antibodies in response to vaccine. Thus, Omicron specific strategies are need to counter infection by this strain. We investigated a collection of approved drugs shown to antagonize the binding of native strain RBD to human ACE2, for their ability to antagonize binding to Omicron strain RBD. While most of the drugs the drugs that antagonize binding to native RBD are also active for Omicron RBD but some were inactive, namely drugs that contain iodine are completely inactive against Omicron RBD. Our data strongly indicate that presence of a single iodine molecule in the drug renders it inactive against Omicron strain. Thus, there is molecular specificity of drugs for antagonizing Omicron strain RBD versus native strain RBD of this virus. Such information will pave way for specific drugs for Omicron. A pragmatic message from our data is that the often-used iodine containing mouth wash and rises may be ineffective in antagonizing receptor binding of Omicron strain.

pharmacology and toxicology↗